( October 14, 2026, 2:38 PM EDT) -- PROVIDENCE, R.I. — CVS Pharmacy Inc. and certain subsidiaries have agreed to pay $315 million to resolve federal allegations that they violated the False Claims Act (FCA) and the Controlled Substances Act (CSA) by filling prescriptions for opioids and other controlled substances that allegedly lacked a legitimate medical purpose and submitting those prescriptions for reimbursement from federal health care programs, the government announced Oct. 13....